Table 2.
Reference(s) | Metabolic Stress | MDP | Tissue | Effect |
---|---|---|---|---|
Aging | ||||
Muzumdar et al. (44), Bachar et al. (1), D’Souza et al. (8) | Aging (human) | Humanin, MOTS-c | Blood | ↓ |
Conte et al. (7) | Aging (human) | Humanin | Blood | ↑ |
D’Souza et al. (8) | Aging (human) | MOTS-c | Muscle | ↑ |
Muzumdar et al. (44), Cobb et al. (6), Lee et al. (31) | Aging (rodent) | Humanin, MOTS-c, SHLP2 | Blood, muscle, hypothalamus | ↓ |
Exercise | ||||
Woodhead et al. (54) | AEx (human) | Humanin | Muscle, blood | ↑,↑ |
Woodhead et al. (54) | TRx (human) | Muscle, blood | ↔, ↓ | |
Woodhead et al. (54) | AEx, TRx (human) | SHLP2 | Blood | ↔ |
Woodhead et al. (54) | AEx, TRx (human) | SHLP6 | Blood | ↑, ↓ |
Reynolds et al. (50) | AEx (human) | MOTS-c | Muscle, blood | ↑,↑ |
Gidlund et al. (11) | TRx (human) | Humanin | Muscle, blood | ↑↔,↔ |
Ramanjenaya et al. (49) | TRx (human) | MOTS-c | Blood | ↔ |
Cardiovascular | ||||
Widmer et al. (53), Zhloba et al. (60), Qin et al. (47) | Heart disease (human) | Humanin | Blood | ↓ |
Mangkhang et al. (37) | Mitral valve disease (canine) | Humanin | Blood | ↓ |
Metabolic disorders | ||||
Ramanjaneya et al. (48) | Type 2 diabetes (human) | Humanin, MOTS-c | Blood | ↓ |
Cataldo et al. (4) | IR (human) | MOTS-c | Blood | ↑ |
Cataldo et al. (4) | Obesity (human) | MOTS-c | Blood | ↔ |
Du et al. (9) | Obesity (human) | MOTS-c | Blood | ↓ |
Liu et al. (33) | Kidney disease (human) | MOTS-c, Humanin | Muscle, blood Muscle, blood Muscle |
↓ ↓,↑ ↑# |
Other | ||||
Lu et al. (35) | Cold exposure (rodent) | MOTS-c | Blood | ↓ |
Ramanjaneya et al. (49) | Intralipid infusion (human) | MOTS-c | Blood | ↑ |
Kariya et al. (19), Kin et al. (25) | mtDNA-related diseases (human) | Humanin | Muscle | ↑ |
AEx, acute exercise bout; blood, serum or plasma; IR, insulin resistance; MDP, mitochondrial-derived peptide; TRx, exercise training. ↑, increase; ↓, decrease; ↔, no change;
Relative to mtDNA.